Worldwide Healthcare (WWH)
Category Sector Equity Healthcare
This investment trust can be held in an Investment ISA, SIPP and Investment Account
Sell
349.00p
Buy
349.50p
-1.50p (-0.43%)
Discount/Premium
-9.75%
Estimated NAV
390.039p
Prices updated at 16 May 2024, 16:35 BST
| Prices minimum 15 mins delay
Prices in GBX
Investment objective
In order to achieve a high level of capital growth, the Company invests in the global healthcare sector and in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector. It uses gearing, and derivative transactions to mitigate risk and also to enhance returns.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Price
- Performance
- Charges & documents
- Shares & trades
- Dividends
- Portfolio
- Risk
- News & dates
- Trust info
- Director info
Company name
Frostrow Capital LLP
Legal structure
Closed Ended Investment Company
Domicile
United Kingdom
Fiscal year end
31 Mar 2025
Launch date
28 Apr 1995
Fund manager
Sven Borho
Manager start date
01 Feb 2013
Fund manager biography
Sven H. Borho, CFA, is a founding General Partner of OrbiMed. Mr. Borho is a portfolio manager for OrbiMed’s public equity funds and he heads the firm’s trading efforts. He started his career in 1991 when he joined Mehta and Isaly as a Senior Analyst covering European pharmaceutical firms and biotechnology companies worldwide. In 1993, Mr. Borho became portfolio manager to investment funds under management. Mr. Borho studied business administration at Bayreuth University in Germany and received a M. Sc. (Econ.) from The London School of Economics; he is a citizen of both Germany and Sweden.
Head office
25 Southampton Buildings
London
United Kingdom
WC2A 1AL
